| Name | Last modified | Size | Description | |
|---|---|---|---|---|
| Parent Directory | - | |||
| financial-results-fy..> | 2023-03-30 02:01 | 11M | ||
| rights-issue-newspap..> | 2023-03-08 02:19 | 4.1M | ||
| Press-Release-16-01-..> | 2023-03-23 03:42 | 3.4M | ||
| investor-call-21-feb..> | 2023-03-11 14:18 | 2.7M | ||
| rights-issue-newspap..> | 2023-03-08 02:19 | 2.5M | ||
| agm-speech-2022.pdf | 2023-03-27 09:30 | 2.4M | ||
| outcome-of-the-board..> | 2023-03-11 13:16 | 2.1M | ||
| press-release-4-8-18..> | 2023-03-22 14:30 | 1.9M | ||
| annual-secretarial-c..> | 2023-03-11 13:33 | 1.7M | ||
| financial-results-de..> | 2023-03-11 12:58 | 1.6M | ||
| Quality-2023.jpg | 2023-03-21 01:12 | 1.4M | ||
| wockhardt-annual-fin..> | 2023-03-22 11:05 | 1.2M | ||
| q2-pressrelufr-final..> | 2023-03-22 10:10 | 1.2M | ||
| nih-usa-16-03-2022.pdf | 2023-03-08 02:19 | 1.2M | ||
| sii-collaboration-se..> | 2023-03-08 02:19 | 1.1M | ||
| wockhardt-q1fy13-pre..> | 2023-03-22 10:11 | 1.1M | ||
| rpt-sept-2022.pdf | 2023-03-10 23:24 | 1.0M | ||
| press-release-q2-fy2..> | 2023-03-23 04:03 | 1.0M | ||
| pr-27122.pdf | 2023-03-23 05:54 | 1.0M | ||
| press-release-q4-fy2..> | 2023-03-23 09:28 | 1.0M | ||
| partnership-with-uk-..> | 2023-03-08 01:32 | 1.0M | ||
| initiation-of-phase-..> | 2023-03-08 07:45 | 953K | ||
| press-release-q2fy23..> | 2023-03-23 09:30 | 940K | ||
| press-release-q3-fy2..> | 2023-03-23 09:30 | 932K | ||
| appt-of-akhilesh-gup..> | 2023-03-08 01:32 | 929K | ||
| shp-september-2022.pdf | 2023-03-11 13:10 | 903K | ||
| appointment-of-cfo-2..> | 2023-03-08 02:19 | 879K | ||
| cdsco-approval-for-e..> | 2023-03-08 02:19 | 851K | ||
| uk-prime-minister-vi..> | 2023-03-08 01:32 | 831K | ||
| investor-call-invite..> | 2023-03-11 14:18 | 820K | ||
| press-release-q1-290..> | 2023-03-23 03:42 | 809K | ||
| press-release-28-1-1..> | 2023-03-23 02:56 | 793K | ||
| press-release-q4-11-..> | 2023-03-23 03:42 | 789K | ||
| nih-16322.pdf | 2023-03-23 05:54 | 785K | ||
| press-release-q4-fy2..> | 2023-03-23 04:03 | 781K | ||
| press-release-q2-211..> | 2023-03-23 03:42 | 777K | ||
| press-release-Q3-9mf..> | 2023-03-23 04:03 | 773K | ||
| press-release-q1-FY2..> | 2023-03-23 04:02 | 770K | ||
| press-release-q1-fy2..> | 2023-03-23 09:30 | 758K | ||
| press-release-10-11-..> | 2023-03-22 14:30 | 756K | ||
| ext-of-covid-19-cont..> | 2023-03-08 01:32 | 742K | ||
| press-release-q4-fy-..> | 2023-03-23 02:56 | 719K | ||
| anti-trust-fair-comp..> | 2023-03-10 23:24 | 704K | ||
| prc-21322.pdf | 2023-03-23 05:55 | 683K | ||
| visit-of-hrh-05-07-2..> | 2023-03-08 02:19 | 675K | ||
| bm-intimation-28-10-..> | 2023-03-11 13:34 | 653K | ||
| prohibition-of-insid..> | 2023-03-10 23:25 | 637K | ||
| press-release-20-04-..> | 2023-03-23 03:42 | 633K | ||
| press-release-wockha..> | 2023-03-23 03:42 | 619K | ||
| wockhardt-ltd-transc..> | 2023-03-11 14:19 | 615K | ||
| rdif-wockhardt-partn..> | 2023-03-08 02:19 | 609K | ||
| Press-Release-Q1FY15..> | 2023-03-22 11:57 | 585K | ||
| press-release-appoin..> | 2023-03-23 03:42 | 567K | ||
| press-release-dec-12..> | 2023-03-22 11:05 | 563K | ||
| statement-of-deviati..> | 2023-03-11 13:34 | 548K | ||
| final-press-release-..> | 2023-03-23 04:02 | 534K | ||
| press-release-13-02-..> | 2023-03-23 03:42 | 528K | ||
| shp-december-2022.pdf | 2023-03-11 13:08 | 525K | ||
| press-release-q4-fy-..> | 2023-03-22 13:30 | 493K | ||
| pr-8222.pdf | 2023-03-23 05:54 | 488K | ||
| press-release-q2fy18..> | 2023-03-22 13:30 | 487K | ||
| press-release-q2-fy-..> | 2023-03-22 13:15 | 484K | ||
| Press-Release-Q3FY15..> | 2023-03-22 11:57 | 483K | ||
| press-release-q1fy18..> | 2023-03-22 13:30 | 480K | ||
| press-release-wockha..> | 2023-03-23 03:42 | 473K | ||
| rights-issue-newspap..> | 2023-03-08 02:19 | 463K | ||
| press-release-14-08-..> | 2023-03-23 02:56 | 447K | ||
| press-release-q2fy14..> | 2023-03-22 11:05 | 438K | ||
| press-release-q1fy14..> | 2023-03-22 11:05 | 437K | ||
| press-release-q3-27-..> | 2023-03-23 03:42 | 434K | ||
| ehs-s-policy-wockhar..> | 2023-03-10 23:25 | 432K | ||
| partnership-with-jem..> | 2023-03-08 02:19 | 430K | ||
| press-release-7-11-1..> | 2023-03-23 02:56 | 417K | ||
| press-release-q3fy18..> | 2023-03-22 14:30 | 414K | ||
| vaccination-rollout-..> | 2023-03-08 02:19 | 413K | ||
| press-release-q3-fy-..> | 2023-03-22 13:30 | 412K | ||
| press-release-q4fy16..> | 2023-03-22 13:15 | 411K | ||
| press-release-q4-fy1..> | 2023-03-22 14:30 | 407K | ||
| press-release-q1fy16..> | 2023-03-22 12:58 | 405K | ||
| press-release-q3FY16..> | 2023-03-22 13:15 | 400K | ||
| press-release-q2fy16..> | 2023-03-22 12:58 | 400K | ||
| se-intimation-restru..> | 2023-03-11 13:34 | 393K | ||
| restructuring-usa-20..> | 2023-03-08 07:45 | 393K | ||
| resignation-of-pramo..> | 2023-03-08 07:45 | 392K | ||
| wockhardt-business-r..> | 2023-03-10 23:25 | 392K | ||
| press-release-anda-o..> | 2023-03-22 12:56 | 389K | ||
| press-release-anda-o..> | 2023-03-22 12:58 | 389K | ||
| uk-vaccine-contract-..> | 2023-03-23 04:03 | 381K | ||
| appt-of-pramod-gupta..> | 2023-03-08 07:45 | 373K | ||
| anti-bribery-and-cor..> | 2023-03-10 23:24 | 370K | ||
| wockhardt-award-pres..> | 2023-03-22 11:05 | 358K | ||
| press-release-wockha..> | 2023-03-23 04:03 | 348K | ||
| press-release-Q2-jul..> | 2023-03-22 11:57 | 341K | ||
| withdrawal-of-nomine..> | 2023-03-08 07:45 | 337K | ||
| new-final-press-rele..> | 2023-03-23 04:02 | 336K | ||
| wockhardt-press-rele..> | 2023-03-22 11:57 | 325K | ||
| wockhardt-receives-a..> | 2023-03-23 02:56 | 324K | ||
| wockhardt-uk-hosts-v..> | 2023-03-23 04:03 | 312K | ||
| wockhardt-receives-a..> | 2023-03-23 02:56 | 307K | ||
| wockhardt-stakeholde..> | 2023-03-10 23:25 | 300K | ||
| dr-khorakiwala-short..> | 2023-03-28 04:43 | 296K | ||
| dr-khorakiwala-profi..> | 2023-03-28 04:44 | 296K | ||
| communication-policy..> | 2023-03-10 23:25 | 284K | ||
| CSR-pic-1.jpg | 2023-03-02 06:35 | 278K | ||
| diversity-inclusion-..> | 2023-03-10 23:25 | 261K | ||
| appointment-of-cs-re..> | 2023-03-08 02:19 | 255K | ||
| wockhardt-anda-press..> | 2023-03-22 10:11 | 243K | ||
| 1-inlicensing-bonist..> | 2023-03-22 02:23 | 243K | ||
| wockhardt-and-approv..> | 2023-03-22 11:05 | 242K | ||
| wockhardt-pressrelea..> | 2023-03-22 10:11 | 242K | ||
| wockhardt-pr-anda-la..> | 2023-03-22 10:11 | 241K | ||
| 8-anda-fexofenadine-..> | 2023-03-22 08:12 | 239K | ||
| 6-derivatives-20-03-..> | 2023-03-22 02:06 | 239K | ||
| 10-usfda-amoxy-clavu..> | 2023-03-22 02:06 | 238K | ||
| wock-press-release-3..> | 2023-03-22 10:11 | 237K | ||
| anda-clopidogrel-tab..> | 2023-03-22 10:10 | 237K | ||
| wockhardt-anda-press..> | 2023-03-22 10:11 | 236K | ||
| 13-wock-abbott-nutri..> | 2023-03-22 02:25 | 235K | ||
| 5-new-products-launc..> | 2023-03-22 08:16 | 234K | ||
| 9-orion-patent-settl..> | 2023-03-22 02:24 | 233K | ||
| 3-anda-venlafaxine-x..> | 2023-03-22 08:16 | 231K | ||
| 7-wock-medical-excel..> | 2023-03-22 02:24 | 231K | ||
| 7-tentative-anda-dul..> | 2023-03-22 08:17 | 231K | ||
| 6-tentative-anda-pat..> | 2023-03-22 08:16 | 230K | ||
| 4-anda-donepezil-tab..> | 2023-03-22 08:16 | 230K | ||
| 1-anda-pantoprazole-..> | 2023-03-22 08:16 | 230K | ||
| 16-anda-tamsulosin-c..> | 2023-03-22 02:25 | 228K | ||
| 2-glaritus-launch-10..> | 2023-03-22 02:23 | 228K | ||
| 18-anda-nicardipine-..> | 2023-03-22 02:25 | 228K | ||
| 17-anda-alfuzosin-01..> | 2023-03-22 02:25 | 228K | ||
| 9-usfda-midazolam-in..> | 2023-03-22 02:06 | 227K | ||
| 12-animal-health-div..> | 2023-03-22 02:24 | 227K | ||
| Q3FY14-Press-Release..> | 2023-03-22 11:57 | 227K | ||
| 15-wock-patent-award..> | 2023-03-22 02:25 | 227K | ||
| 3-anda-divalproex-er..> | 2023-03-22 02:24 | 226K | ||
| 5-usfda-fosphenytoin..> | 2023-03-22 01:33 | 226K | ||
| 7-inlicensing-sincla..> | 2023-03-22 02:06 | 225K | ||
| 6-anda-ranitidine-sy..> | 2023-03-22 02:24 | 224K | ||
| 5-anda-sumatriptan-v..> | 2023-03-22 02:24 | 223K | ||
| 2-wock-sheffield.pdf | 2023-03-22 08:16 | 223K | ||
| 8-new-board-of-direc..> | 2023-03-22 02:24 | 221K | ||
| us-diana-award.pdf | 2023-03-22 10:11 | 221K | ||
| 4-anda-leveiracetam-..> | 2023-03-22 02:24 | 221K | ||
| 11-esparma-divestmen..> | 2023-03-22 02:24 | 221K | ||
| 8-wock-morton-grove-..> | 2023-03-22 01:40 | 220K | ||
| 14-animal-health-div..> | 2023-03-22 02:25 | 220K | ||
| wus-pr-stalevolaunch..> | 2023-03-22 10:11 | 219K | ||
| 6-inlicensing-zindac..> | 2023-03-22 01:33 | 217K | ||
| 7-inlicensing-sammy-..> | 2023-03-22 01:33 | 216K | ||
| 8-usfda-ceftazidime-..> | 2023-03-22 02:06 | 216K | ||
| 10-wock-new-auditor-..> | 2023-03-22 02:24 | 209K | ||
| press-release-on-nce..> | 2023-03-22 13:30 | 202K | ||
| Wockhardt-55-years-j..> | 2023-03-13 15:38 | 201K | ||
| human-right-policy.pdf | 2023-03-10 23:25 | 199K | ||
| l-d-initiatives.jpg | 2023-03-28 02:05 | 195K | ||
| our-business.jpg | 2023-03-28 06:23 | 184K | ||
| Press-Release-Q4FY14..> | 2023-03-22 11:57 | 183K | ||
| press-release-qtr-1-..> | 2023-03-22 13:15 | 174K | ||
| wockhardt-receives-a..> | 2023-03-23 02:56 | 170K | ||
| life-wockhardt.jpg | 2023-03-28 02:05 | 154K | ||
| uk.jpg | 2023-03-07 02:02 | 133K | ||
| switzerland.jpg | 2023-03-07 02:02 | 133K | ||
| ireland.jpg | 2023-03-07 02:02 | 133K | ||
| France.jpg | 2023-03-11 12:16 | 133K | ||
| global-hq.jpg | 2023-03-11 12:16 | 131K | ||
| usa-llc.jpg | 2023-03-07 02:02 | 130K | ||
| usa-monton.jpg | 2023-03-07 02:03 | 129K | ||
| wockhardt-pr-anda-en..> | 2023-03-22 10:11 | 127K | ||
| introduction.jpg | 2023-03-28 02:05 | 122K | ||
| anda-alfuzosiner-v1d..> | 2023-03-22 10:10 | 120K | ||
| the-wockhardt-2.jpg | 2023-03-28 02:51 | 103K | ||
| press-release-dubai-..> | 2023-03-22 14:30 | 102K | ||
| the-wockhardt-3.jpg | 2023-03-28 03:02 | 98K | ||
| wbl-acquisition-09-1..> | 2023-03-08 02:19 | 93K | ||
| vaccine-manufacturin..> | 2023-03-08 02:19 | 90K | ||
| Wockhardt-55-years-p..> | 2023-03-13 15:38 | 87K | ||
| career-wockhardt.jpg | 2023-03-28 02:05 | 74K | ||
| press-release-22june..> | 2023-03-22 13:30 | 73K | ||
| 07_CLSI-AST-News-Upd..> | 2023-03-10 05:52 | 73K | ||
| 08_International_Jou..> | 2023-03-10 00:58 | 68K | ||
| COVID-19-vaccine.jpg | 2023-03-28 08:38 | 68K | ||
| 04_Regulatory_Toxico..> | 2023-03-10 05:12 | 65K | ||
| 03_JAC_Antimicrobial..> | 2023-03-10 05:13 | 61K | ||
| pr-07-08-2017.pdf | 2023-03-22 13:30 | 60K | ||
| nce-1.jpg | 2023-03-11 12:16 | 60K | ||
| press-release-3-7-20..> | 2023-03-22 13:30 | 59K | ||
| 02_International_Jou..> | 2023-03-10 05:50 | 56K | ||
| 23_aeruginosa_Journa..> | 2023-03-18 06:22 | 53K | ||
| 14_Sachin_S_Bhagwat_..> | 2023-03-10 00:59 | 53K | ||
| 07_Diagnostic_Microb..> | 2023-03-10 00:58 | 53K | ||
| 06_Journal-of-Cytoki..> | 2023-03-10 05:12 | 49K | ||
| CNBC-TV18.jpg | 2023-03-28 08:34 | 41K | ||
| Investor-Call.jpg | 2023-03-28 08:38 | 37K | ||
| us-fda-grants-breakt..> | 2023-03-22 13:03 | 35K | ||
| 06_Antibiotics.jpg | 2023-03-10 00:57 | 33K | ||
| digital-footprint.jpg | 2023-03-27 09:02 | 33K | ||
| digital-footprint-1.jpg | 2023-03-28 03:25 | 33K | ||
| mahesh-v-patel-1.png | 2023-03-27 08:08 | 32K | ||
| 32_Biomedical-Chroma..> | 2023-03-10 01:11 | 30K | ||
| 09_Analytical-Chemis..> | 2023-03-10 05:11 | 29K | ||
| image-1.png | 2023-03-23 01:37 | 27K | ||
| 01_Research-on-Chemi..> | 2023-03-10 05:13 | 22K | ||
| 05_Xenobiotica.jpg | 2023-03-10 05:12 | 22K | ||
| 08_Chromatographia.jpg | 2023-03-10 05:12 | 22K | ||
| chairman-info.jpg | 2023-03-28 04:42 | 20K | ||
| 03_Microbiology_Spec..> | 2023-03-10 00:55 | 19K | ||
| life-wins.jpg | 2023-03-28 03:23 | 19K | ||
| 10_Bioanalysis.jpg | 2023-03-10 05:11 | 16K | ||
| 12_Determination_of_..> | 2023-03-10 05:10 | 16K | ||
| 15_mBio.jpg | 2023-03-10 00:59 | 15K | ||
| Ravi-Limaye.jpg | 2023-03-13 18:07 | 14K | ||
| Sanjeev-kumar.jpg | 2023-03-13 18:07 | 14K | ||
| Prakash-Gupta.jpg | 2023-03-13 18:07 | 14K | ||
| 05_Antimicrobial-Age..> | 2023-03-10 00:57 | 14K | ||
| 02_Antimicrobial-Age..> | 2023-03-10 05:13 | 14K | ||
| Ajay-Sohni.jpg | 2023-03-13 18:07 | 14K | ||
| Amrut-Medhekar.jpg | 2023-03-13 18:07 | 13K | ||
| avijit-deb.jpg | 2023-03-27 08:07 | 13K | ||
| Wockhardt-55-years-s..> | 2023-03-13 15:38 | 12K | ||
| logo-image-55.jpg | 2023-03-13 15:21 | 11K | ||
| 30_aGram-negative_Jo..> | 2023-03-10 01:08 | 8.7K | ||
